睡眠輔助產品市場規模、佔有率、成長分析、按產品類型、按睡眠障礙、按分銷管道、按最終用戶、按地區 - 行業預測，2024-2031 年

2022年全球睡眠輔助市場規模為780億美元，從2023年的822.1億美元成長到2031年的1252.2億美元，預計在預測期內（2024-2031年）複合年成長率為5.4%。 。

睡眠障礙會對日常功能產生重大影響，導致白天過度嗜睡，並加劇學術和工作環境、心理健康、人際關係以及心臟病和糖尿病等慢性疾病的風險。常見病症包括失眠、睡眠呼吸中止症、不寧腿症候群和發作性睡病。治療選擇範圍從匹托利桑、Modafinil和Modafinil等藥物到褪黑激素和Zaleplon等治療和非處方補充品。儘管運動和環境控制等生活方式調整可以改善睡眠質量，但藥物的潛在副作用和患者不依從率較高可能會阻礙睡眠輔助市場的成長。展望 2024 年，應對這些挑戰對於尋求改善睡眠健康的市場相關人員和醫療保健提供者至關重要。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 監管環境
• 專利分析
• 案例研究
• 客戶和購買標準分析

睡眠輔助市場規模：依產品類型

• 市場概況
• 床墊和枕頭
• 藥品
  • 根據處方箋
  • 店面銷售(OTC)
• 睡眠呼吸中止症裝置
  • 正壓呼吸器(PAP)設備
  • 自適應伺服通氣 (ASV) 裝置
  • 口腔矯正器
  • 面具及配件
• 睡眠研究所
• 其他產品
  • 睡眠追蹤裝置
  • 白噪音機

睡眠輔助市場規模：依睡眠障礙分類

• 市場概況
• 失眠
• 睡眠呼吸中止症
• 不寧腿
• 發作性睡病
• 夢遊
• 其他睡眠障礙

睡眠輔助產品市場規模：依通路分類

• 市場概況
• 零售藥房
• 醫院藥房
• 網路藥房
• 睡眠診所
• 其他

睡眠輔助市場規模：依最終用戶分類

• 市場概況
• 成人
• 孩子
• 老年人

睡眠輔助市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Merck & Co., Inc.（USA）
• Sanofi（France）
• Koninklijke Philips NV（Netherlands）
• Pfizer Inc.（USA）
• GlaxoSmithKline PLC（UK）
• SleepMed Inc.（USA）
• Cadwell Laboratories Inc.（USA）
• Natus Medical Incorporated（USA）
• Fisher & Paykel Healthcare（New Zealand）
• ResMed Inc.（USA）
• Teva Pharmaceutical Industries Ltd.（Israel）
• AstraZeneca（UK）
• Takeda Pharmaceutical Company Limited（Japan）
• Vanda Pharmaceuticals Inc.（USA）
• Mylan NV（USA）
• Koninklijke Philips NV（Netherlands）

結論和建議

Global Sleep Aids Market size was valued at USD 78.0 billion in 2022 and is poised to grow from USD 82.21 billion in 2023 to USD 125.22 billion by 2031, growing at a CAGR of 5.4% during the forecast period (2024-2031).

Sleep disorders significantly affect daily functioning, contributing to excessive daytime sleepiness and exacerbating challenges in academic and professional settings, mental well-being, interpersonal relationships, and the risk of chronic conditions like heart disease and diabetes. Common disorders include insomnia, sleep apnea, restless legs syndrome, and narcolepsy. Treatment options range from pharmaceutical solutions such as pitolisant, modafinil, and armodafinil to therapies and over-the-counter supplements like melatonin and zaleplon. While lifestyle adjustments like exercise and environmental control can enhance sleep quality, potential side effects of medications and high rates of patient non-adherence may hinder growth in the sleep aids market. As we approach 2024, addressing these challenges will be crucial for market stakeholders and healthcare providers aiming to improve sleep health.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sleep Aids market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Sleep Aids Market Segmental Analysis

Global Sleep Aids Market is segmented by product type, sleep disorder, distribution channel, end-user and region. Based on product type, the market is segmented into mattresses & pillows, medications, sleep apnea devices, sleep laboratories and other products. Based on sleep disorder, the market is segmented into insomnia, sleep apnea, restless legs syndrome, narcolepsy, sleepwalking and other sleep disorders. Based on distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, sleep clinics and others. Based on end-user, the market is segmented into adults, children and elderly. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Sleep Aids Market

The primary impetus behind the expansion of the global sleep aids market is the evolving sleep patterns among people, driven by contemporary lifestyles. As individuals grapple with increased stress, demanding work schedules, and technology-induced sleep disruption, the need for effective sleep solutions has surged. Additionally, rising disposable incomes and enhanced healthcare access are likely to further fuel the demand for sleep aids over the coming years. This convergence of factors-modern living challenges and heightened health consciousness-positions the sleep aids market for robust growth in the foreseeable future, as consumers seek out products that promote better sleep quality and overall well-being.

Restraints in the Global Sleep Aids Market

The Global Sleep Aids market faces significant challenges due to the rising complexity of treating sleep disorders driven by advanced technological innovations. Moreover, the absence of adequate regulatory documentation for the prescription and utilization of sleep medications, coupled with improper settings on sleep devices, hampers effective treatment options. These issues contribute to a stagnation in market growth, as consumers and healthcare providers grapple with the limitations of current solutions. As a result, the potential for expansion in the sleep aids market is stifled, hindering advancements in product development and overall accessibility to effective treatment alternatives for individuals experiencing sleep disturbances.

Market Trends of the Global Sleep Aids Market

The Global Sleep Aids market is experiencing significant growth, driven by rising consumer awareness of sleep-related disorders and the increasing prevalence of issues such as restless leg syndrome and narcolepsy. Innovative products like sleep-inducing pillows and mattresses are gaining traction among health-conscious consumers seeking better sleep quality. The burgeoning demand for both pharmaceutical and non-pharmaceutical sleep solutions reflects a broader trend towards holistic wellness. As people continue to prioritize sleep as a critical factor in overall health, the market is poised for further expansion, generating substantial revenue opportunities for manufacturers and suppliers within the sleep aids sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Case Studies
• Customer & Buying Criteria Analysis

Global Sleep Aids Market Size by Product Type & CAGR (2024-2031)

• Market Overview
• Mattresses & Pillows
• Medications
  • Prescription-Based
  • Over-The-Counter (OTC)
• Sleep Apnea Devices
  • Positive Airway Pressure (PAP) Devices
  • Adaptive Servo-Ventilation (ASV) Devices
  • Oral Appliances
  • Masks & Accessories
• Sleep Laboratories
• Other Products
  • Sleep Tracking Devices
  • White Noise Machines

Global Sleep Aids Market Size by Sleep Disorder & CAGR (2024-2031)

• Market Overview
• Insomnia
• Sleep Apnea
• Restless Legs Syndrome
• Narcolepsy
• Sleep Walking
• Other Sleep Disorders

Global Sleep Aids Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Sleep Clinics
• Others

Global Sleep Aids Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Adults
• Children
• Elderly

Global Sleep Aids Market Size & CAGR (2024-2031)

• North America (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • USA
  • Canada
• Europe (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SleepMed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cadwell Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natus Medical Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fisher & Paykel Healthcare (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ResMed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vanda Pharmaceuticals Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations